Saturday, July 4, 2009
New CEO Chris Viehbacher reveals his plans for sanofi-aventis, plus a report from the frontline of the battle between generics and branded products.
Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Editor’s Blog
Where our team of editors discuss what they think about the current NGP US Issues.
Marie Shields
Editor NGP US
Editor NGP US
No Comments
Editor’s Choice
-
New Concepts in Risk Control
Bayer’s Helmut Mothes examines the success of Lean and the development of operational excellence.Read more -
Balancing Act
Novartis’ Sammy Rashed talks to NGP about ensuring supply chain security in turbulent times.Read more -
Thought Leader
Realigning from the company from within to keep up with the ever-changing vitality of pharma manufacturing has been no mean feat for Novartis’ Steve Dreamer.Read more -
A Flash of Insight
Johnson & Johnson’s Qingqin Li tells NGP how bioinformatics helps us to understand biological processes.Read more -
Changing Times
Wyeth’s Thorir Bjornsson talks to NGP about dealing with attrition, the fallout from the merger with Pfizer, and what the future holds for the industry.Read more -
Complications
Amgen’s Alexander Kamb explains why cancer may be more genetically complex than we originally believed.Read more
Readers’ Choice
-
Breaking New Ground
Sean Harper tells NGP why he is excited about potential new treatments for osteoporosis, why animal models aren't always useful in developing drugs for humans, and why the...Read more -
Customer Centric Service: The New Rx fo...
As the industry moves from its traditional sales and marketing approach to customer centric service models, companies are seeking to better meet physicians’ need for product,...Read more -
Early Phase Research – The Problem, the ...
Members of product development teams typically visit the Phase I-II world every few years. Increasingly, however, they are finding it a different world at each visit, due to a...Read more -
The Enterprise Lab Notebook
Enabling multi-disciplinary virtual teams to improve R&D productivity through knowledge sharing. By Symyx Technologies, Inc.Read more -
Money for Nothing
Where is this new round of mergers and acquisitions coming from? Is the pharmaceutical industry in danger of consuming itself in its endless quest for profit?Read more -
Performance Validation, LLC Next Generat...
Customer centric focus: Customer focus has been defined as placing the wants and needs of the customer as the central focus of all business practices within the company. By...Read more
Search
Quick Vote
Should consumers be given greater access to generic drugs?
Executive Interviews
Trial and Error
Beth Harper of Clinical Performance Partners, Inc. explains the correct procedures needed to ensure a successful clinical study.
Read more
New Commercial Models
Sati Sian of IMS Health discusses the industry’s development of new commercial models.
Read more
The Evolution of Communications
Jay Bigelow of MicroMass Communications examines the changing methods of keeping in touch with your customers.
Read more
Next Generation Healthcare Summit 2009
30th September - 2nd October
As healthcare costs continue to rise, health providers around the country feel a sharp sense of urgency in deploying information technology to lower costs, reduce medical errors, enhance outcomes, and spur efficiency in an industry known for legendary inefficiency.
Source: www.ngpharma.com© 2009 GDS Publishing Ltd. All rights reserved.